221 related articles for article (PubMed ID: 4039188)
1. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
McKenna WJ; Oakley CM; Krikler DM; Goodwin JF
Br Heart J; 1985 Apr; 53(4):412-6. PubMed ID: 4039188
[TBL] [Abstract][Full Text] [Related]
2. Improved survival with amiodarone in patients with hypertrophic cardiomyopathy and ventricular tachycardia.
Crick JC
Br Heart J; 1985 Nov; 54(5):550-1. PubMed ID: 4052297
[No Abstract] [Full Text] [Related]
3. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population.
Cecchi F; Olivotto I; Montereggi A; Squillatini G; Dolara A; Maron BJ
Heart; 1998 Apr; 79(4):331-6. PubMed ID: 9616338
[TBL] [Abstract][Full Text] [Related]
4. [Arrhythmias in hypertrophic cardiomyopathy. Significance and therapeutic consequences].
McKenna WJ; Kleinebenne A
Herz; 1985 Apr; 10(2):91-101. PubMed ID: 2580767
[TBL] [Abstract][Full Text] [Related]
5. Amiodarone for long-term management of patients with hypertrophic cardiomyopathy.
McKenna WJ; Harris L; Rowland E; Kleinebenne A; Krikler DM; Oakley CM; Goodwin JF
Am J Cardiol; 1984 Oct; 54(7):802-10. PubMed ID: 6541429
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of 24 hour ambulatory electrocardiographic monitoring in patients with hypertrophic cardiomyopathy: a prospective study.
Maron BJ; Savage DD; Wolfson JK; Epstein SE
Am J Cardiol; 1981 Aug; 48(2):252-7. PubMed ID: 7196685
[TBL] [Abstract][Full Text] [Related]
7. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone.
McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN
Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300
[TBL] [Abstract][Full Text] [Related]
8. Nonsustained ventricular tachycardia as a predictor for sudden death in patients with idiopathic dilated cardiomyopathy. The role of amiodarone treatment.
Castelli G; Ciaccheri M; Cecchi F; Troiani V; Nannini M; Marconi P; Olivotto J; Montereggi A; Dolara A
G Ital Cardiol; 1999 May; 29(5):514-23. PubMed ID: 10367218
[TBL] [Abstract][Full Text] [Related]
9. Sudden death during empiric amiodarone therapy in symptomatic hypertrophic cardiomyopathy.
Fananapazir L; Leon MB; Bonow RO; Tracy CM; Cannon RO; Epstein SE
Am J Cardiol; 1991 Jan; 67(2):169-74. PubMed ID: 1987718
[TBL] [Abstract][Full Text] [Related]
10. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation.
Morady F; Scheinman MM; Hess DS
Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299
[TBL] [Abstract][Full Text] [Related]
11. Arrhythmia and prognosis in hypertrophic cardiomyopathy.
McKenna WJ
Eur Heart J; 1983 Nov; 4 Suppl F():225-34. PubMed ID: 6686539
[TBL] [Abstract][Full Text] [Related]
12. [Ambulatory ECG in cardiomyopathies].
Mestroni L; Miani D; Neri R; Di Lenarda A; Camerini F
G Ital Cardiol; 1987 Dec; 17(12):1139-44. PubMed ID: 3503812
[TBL] [Abstract][Full Text] [Related]
13. Does treatment influence the natural history of patients with hypertrophic cardiomyopathy?
McKenna WJ
Drugs; 1985 Mar; 29 Suppl 3():53-6. PubMed ID: 4039653
[TBL] [Abstract][Full Text] [Related]
14. Antiarrhythmic efficacy of amiodarone in recurrent ventricular tachycardia evaluated by multiple electrophysiological and ambulatory ECG recordings.
Rasmussen K; Winkle R; Ross D; Griffin J; Peters F; Mason J
Acta Med Scand; 1982; 212(6):367-74. PubMed ID: 6760675
[TBL] [Abstract][Full Text] [Related]
15. Long term-treatment of ventricular tachycardia in ambulatory patients with amiodarone.
Vazquez Blanco M; Milei J; Piñeiro DJ; Buceta JE; Dreyer MP
Acta Cardiol; 1983; 38(2):125-32. PubMed ID: 6603085
[TBL] [Abstract][Full Text] [Related]
16. Amiodarone in the treatment of life-threatening ventricular tachycardia: role of Holter monitoring in predicting long-term clinical efficacy.
Veltri EP; Reid PR; Platia EV; Griffith LS
J Am Coll Cardiol; 1985 Oct; 6(4):806-13. PubMed ID: 3928726
[TBL] [Abstract][Full Text] [Related]
17. Value of electrophysiologic studies in hypertrophic cardiomyopathy treated with amiodarone.
Fananapazir L; Epstein SE
Am J Cardiol; 1991 Jan; 67(2):175-82. PubMed ID: 1987719
[TBL] [Abstract][Full Text] [Related]
18. Sudden death in hypertrophic and dilated cardiomyopathy.
Koga Y; Ogata M; Kihara K; Tsubaki K; Toshima H
Jpn Circ J; 1989 Dec; 53(12):1546-56. PubMed ID: 2632825
[TBL] [Abstract][Full Text] [Related]
19. Amiodarone in refractory life-threatening ventricular arrhythmias.
Nademanee K; Singh BN; Hendrickson J; Intarachot V; Lopez B; Feld G; Cannom DS; Weiss JL
Ann Intern Med; 1983 May; 98(5 Pt 1):577-84. PubMed ID: 6846970
[TBL] [Abstract][Full Text] [Related]
20. Control of recurrent supraventricular tachycardia with amiodarone hydrochloride.
Swan JH; Chisholm AW
Can Med Assoc J; 1976 Jan; 114(1):43-4. PubMed ID: 943223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
